CSF biomarkers and neuropsychological profiles in patients with cerebral small-vessel disease

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Hermann, Peter ^a   Romero, Carlos ^c   Schmidt, Christian ^a   Reis, Clemens ^a   Zerr, Inga ^a,b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c FLENI   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; PHOSPHOPROTEIN; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; CASE CONTROL STUDY; CEREBROSPINAL FLUID ANALYSIS; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; EXECUTIVE FUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL DETERIORATION; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGY; WHITE MATTER LESION; CEREBRAL SMALL VESSEL DISEASES; CEREBROSPINAL FLUID; DEMENTIA, VASCULAR; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CEREBRAL SMALL VESSEL DISEASES; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 84929054415     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105000     Document Type: Article

References (23)

1. Jellinger KA (2008) The pathology of "vascular dementia": a critical update. J Alzheimers Dis 14(1): 107-23.
2. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, et al. (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43(2): 250-60.
3. Broderick DF, Schweitzer KJ, Wszolek ZK (2009) Vascular risk factors and dementia: how to move forward? Neurology 73(22): 1934-5.
4. Pohjasvaara T, Mantyla R, Ylikoski R, Kaste M, Erkinjuntti T (2000) Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences. Stroke 31(12): 2952-7.
5. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC (2002) Subcortical ischaemic vascular dementia. Lancet Neurol 1(7): 426-36.
6. Cavalieri M, Enzinger C, Petrovic K, Pluta-Fuerst A, Homayoon N, et al. (2010) Vascular dementia and Alzheimer's disease - are we in a dead-end road? Neurodegener Dis 7(1-3): 122-6.
7. Hachinski VC, Potter P, Merskey H (1987) Leuko-araiosis. Arch Neurol 44(1): 21-3.
8. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, et al. (2001) A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32(6): 1318-22.
9. Schmidtke K, Hüll M (2002) Neuropsychological differentiation of small vessel disease, Alzheimer's disease and mixed dementia. J Neurol Sci 203-204: 17-22.
10. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, et al. (2006) National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 37(9): 2220-41.
11. Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33(1): 95-130.
12. Hu YY, He SS, Wang X, Duan QH, Grundke-Iqbal I, et al. (2002) Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients: an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay. Am J Pathol 160(4): 1269-78.
13. Lewczuk P, Esselmann H, Otto M, Maler JM, Henkel MK, et al. (2004) Neurochemical diagnosis of Alzheimer's dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau. Neurobiol Aging 25: 273-81.
14. Bibl M, Mollenhauer B, Esselmann H, Schneider M, Lewczuk P, et al. (2008) Cerebrospinal fluid neurochemical phenotypes in vascular dementias: original data and mini-review. Dement Geriatr Cogn Disord 25(3): 256-65.
15. Jonsson M, Zetterberg H, van Straaten E, Lind K, Syversen S, et al. (2009) Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study. Eur J Neurol 17(3): 377-82.
16. Sjogren M, Blomberg M, Jonsson M, Wahlund LO, Edman A, et al. (2001) Neurofilament protein in cerebrospinal fluid: a marker of white matter changes. J Neurosci Res 66(3): 510-6.
17. Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, et al. (1986) CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149: 698-709.
18. Farrall AJ, Wardlaw JM (2009) Blood-brain barrier: Ageing and microvascular disease - systematic review and meta-analysis. Neurobiol Aging 30(3): 337-52.
19. Ma KC, Olsson Y (1997) The role of chronic brain oedema in the formation of lacunes in Binswanger's encephalopathy. Cerebrovasc Dis 7: 324-31.
20. Verdelho A, Madureira S, Moleiro C, Ferro JM, Santos CO, et al. (2010) White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology 75(2): 160-7.
21. Nitkunan A, Barrick TR, Charlton RA, Clark CA, Markus HS (2008) Multimodal MRI in cerebral small vessel disease: its relationship with cognition and sensitivity to change over time. Stroke 39(7): 1999-2005.
22. Silbert LC, Howieson DB, Dodge H, Kaye JA (2009) Cognitive impairment risk: white matter hyperintensity progression matters. Neurology 73(2): 120-5.
23. Bronge L, Wahlund LO (2003) Prognostic significance of white matter changes in a memory clinic population. Psychiatry Res 122(3): 199-206.